Cargando...
Overcoming Endocrine Resistance in Breast Cancer
Estrogen receptor-positive (ER(+)) breast cancer is the most common breast cancer subtype. Treatment of ER(+) breast cancer comprises interventions that suppress estrogen production and/or target the ER directly (overall labeled as endocrine therapy). While endocrine therapy has considerably reduced...
Gardado en:
| Publicado en: | Cancer Cell |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7169993/ https://ncbi.nlm.nih.gov/pubmed/32289273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2020.03.009 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|